Quince Therapeutics, Inc. (QNCX) earnings
QNCX earnings moved a median of -0.57% by the close. Quarterly and annual QNCX reports and results, each read against the price at its own news timestamp. Back to the QNCX overview →
20 measured QNCX earnings events.
Where these QNCX earnings landedvs 16 measured QNCX earnings reactions
| Middle 50% of QNCX earnings reactions | -3.09% to +4.24% |
|---|---|
| Median reaction (to close) | -0.57% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 QNCX earnings events with a measured close landed between -3.09% and +4.24%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Quince Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.38% | |
| Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update | Press release | +5.32% | +7.11% | |
| Form 10-Q Quince Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.41% | +3.28% | |
| Form 10-K Quince Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -3.88% | +9.30% | |
| Form NT 10-K Quince Therapeutics, For: Dec 31 | SEC filing · Form NT | -5.40% | -1.00% | |
| Form 10-Q Quince Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -2.63% | — | |
| Quince Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results | Press release | -2.63% | — | |
| Form 10-Q Quince Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | — | |
| Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results | Press release | +0.00% | — | |
| Form 10-Q Quince Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -0.98% | -6.86% | |
| Quince Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results | Press release | -0.98% | -6.86% | |
| Form 10-K Quince Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.21% | +0.73% | |
| Form 10-Q Quince Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +4.49% | +21.80% | |
| Quince Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results | Press release | +4.49% | +21.80% | |
| Form 10-Q Quince Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +3.45% | -5.22% | |
| Quince Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results | Press release | +3.45% | -5.22% | |
| Form 10-Q Quince Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -0.20% | |
| Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results | Press release | +0.00% | -0.20% | |
| Form 10-K Quince Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -0.94% | |
| Form 10-Q Quince Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.29% | -1.11% |
Keep exploring
More QNCX: analyst actions → · SEC filings → · QNCX overview →